Fineline Cube

Follow:
14436 Articles
Sanofi's Qfitlia Approved by FDA for Hemophilia A and B Prophylaxis
CompanyDrug

Sanofi’s Qfitlia Approved by FDA for Hemophilia A and B Prophylaxis

Brii Biosciences Presents Elebsiran Phase II Data at APASL 2025 Meeting
CompanyDrug

Brii Biosciences Presents Elebsiran Phase II Data at APASL 2025 Meeting

Akeso Biopharma Reports 53% Revenue Decline in 2024 Despite Growth in Product Sales
Company

Akeso Biopharma Reports 53% Revenue Decline in 2024 Despite Growth in Product Sales

IASO Biotherapeutics' Fucaso Approved in Macao for Relapsed Multiple Myeloma
CompanyDrug

IASO Biotherapeutics’ Fucaso Approved in Macao for Relapsed Multiple Myeloma

Eli Lilly Launches Kisunla in China for Early Alzheimer's Treatment
CompanyDrug

Eli Lilly Launches Kisunla in China for Early Alzheimer’s Treatment

Laekna Submits Revised Protocol for LAE102 Obesity Trial with Eli Lilly
CompanyDrug

Laekna Submits Revised Protocol for LAE102 Obesity Trial with Eli Lilly

Apollomics Partners with LaunXP for Vebreltinib in Asian NSCLC Treatment
CompanyDeals

Apollomics Partners with LaunXP for Vebreltinib in Asian NSCLC Treatment

Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone
CompanyDeals

Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone

EClinCloud Secures New Funding to Accelerate AI Innovation in Clinical Research
Company

EClinCloud Secures New Funding to Accelerate AI Innovation in Clinical Research

China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled
Medical DevicePolicy / Regulatory

China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled

Policy Analysis: Shanghai's 2025 Pharmaceutical Procurement Regulation and Market Implications
Policy / Regulatory

Policy Analysis: Shanghai’s 2025 Pharmaceutical Procurement Regulation and Market Implications

Guangdong Accelerates Centralized Procurement for Apixaban and Key Therapeutics
Policy / Regulatory

Guangdong Accelerates Centralized Procurement for Apixaban and Key Therapeutics